{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T13:25:25Z","timestamp":1770729925336,"version":"3.49.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100030732","name":"MSD","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100030732","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Treatment and Research Communications"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.ctarc.2025.101056","type":"journal-article","created":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T00:34:54Z","timestamp":1764722094000},"page":"101056","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Impact of patient and tumor characteristics on various aspects of the non-small cell lung cancer patient journey in Romania, Bulgaria, Serbia: A multicenter, non-interventional, retrospective cohort study"],"prefix":"10.1016","volume":"46","author":[{"given":"Alexandra C.","family":"Preda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rossitza","family":"Krasteva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mihailo","family":"Stjepanovi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krassimir","family":"Koynov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Assia","family":"Konsoulova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgeta P.","family":"Iorga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anghel A.","family":"Udrea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anca","family":"Zgura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tudor-Eliade","family":"Ciuleanu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raluca","family":"Patru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeliazko","family":"Arabadjiev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivan","family":"Tonev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zoran","family":"Andri\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Goran","family":"Stojanovi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mihaela","family":"Pasca-Fenesan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edvina-Elena","family":"Pirvu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bojidar","family":"Iliev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivan","family":"Kazmukov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angel","family":"Petrov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neda","family":"Nikoli\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina","family":"Mushmova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivana","family":"Simic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oana R.","family":"Georgescu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Schenker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.ctarc.2025.101056_bib0002","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1097\/JTO.0000000000000630","article-title":"The 2015 world health organization classification of lung tumors: impact of genetic, clinical and radiologic advances since the 2004 classification","volume":"10","author":"Travis","year":"2015","journal-title":"J. Thorac. Oncol."},{"issue":"7","key":"10.1016\/j.ctarc.2025.101056_bib0003","article-title":"Emerging precision neoadjuvant systemic therapy for patients with resectable non-small cell lung cancer: current status and perspectives","volume":"11","author":"Godoy","year":"2023","journal-title":"Biomark. Res."},{"issue":"12","key":"10.1016\/j.ctarc.2025.101056_bib0004","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/j.annonc.2021.08.1994","article-title":"Early and locally advanced non-small-cell lung cancer: an update of the ESMO clinical practice guidelines focusing on diagnosis, staging, systemic and local therapy","volume":"32","author":"Remon","year":"2021","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ctarc.2025.101056_bib0005","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1001\/jamaoncol.2021.4932","article-title":"Update of incidence, prevalence, survival, and initial treatment in patients with non-small cell lung cancer in the US","volume":"7","author":"Ganti","year":"2021","journal-title":"JAMa Oncol."},{"issue":"9","key":"10.1016\/j.ctarc.2025.101056_bib0006","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.170070","article-title":"Progress and prospects of early detection in lung cancer","volume":"7","author":"Blandin Knight","year":"2017","journal-title":"Open. Biol."},{"issue":"38","key":"10.1016\/j.ctarc.2025.101056_bib0010","article-title":"New systemic treatment paradigms in resectable non-small cell lung cancer and variations in patient access across Europe","volume":"4","author":"Houda","year":"2024","journal-title":"Lancet Reg. Health Eur."},{"issue":"Suppl 4","key":"10.1016\/j.ctarc.2025.101056_bib0011","doi-asserted-by":"crossref","first-page":":iv192","DOI":"10.1093\/annonc\/mdy275","article-title":"Metastatic non-small cell lung cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"29","author":"Planchard","year":"2018","journal-title":"Ann. Oncol."},{"issue":"4","key":"10.1016\/j.ctarc.2025.101056_bib0012","doi-asserted-by":"crossref","first-page":"504","DOI":"10.6004\/jnccn.2017.0050","article-title":"Non-small cell lung cancer, version 5.2017, NCCN clinical practice guidelines in oncology","volume":"15","author":"Ettinger","year":"2017","journal-title":"J. Natl. Compr. Canc. Netw."},{"key":"10.1016\/j.ctarc.2025.101056_bib0013","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/s41392-019-0099-9","article-title":"The emerging treatment landscape of targeted therapy in non-small-cell lung cancer","volume":"4","author":"Yuan","year":"2019","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"4","key":"10.1016\/j.ctarc.2025.101056_bib0014","doi-asserted-by":"crossref","first-page":"199","DOI":"10.4132\/jptm.2019.04.24","article-title":"PD-L1 Testing in Non-small Cell Lung Cancer: Past, Present, and Future [published correction appears in","volume":"53","author":"Kim","year":"2019","journal-title":"J. Pathol. Transl. Med."},{"key":"10.1016\/j.ctarc.2025.101056_bib0015","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ctrv.2019.03.004","article-title":"Choosing wisely first line immunotherapy in non-small cell lung cancer (NSCLC): what to add and what to leave out","volume":"75","author":"Proto","year":"2019","journal-title":"Cancer Treat. Rev."},{"issue":"6","key":"10.1016\/j.ctarc.2025.101056_bib0016","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/s41571-019-0173-9","article-title":"Comparing and contrasting predictive biomarkers for immunotherapy and targeted therapy of NSCLC","volume":"16","author":"Camidge","year":"2019","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.ctarc.2025.101056_bib0017","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2217\/imt-2017-0121","article-title":"Pembrolizumab as first-line therapy for metastatic non-small-cell lung cancer","volume":"10","author":"Reck","year":"2018","journal-title":"Immunotherapy"},{"issue":"9","key":"10.1016\/j.ctarc.2025.101056_bib0018","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1056\/NEJMra1703413","article-title":"Precision diagnosis and treatment for advanced non-small-cell lung cancer","volume":"377","author":"Reck","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"5 Suppl","key":"10.1016\/j.ctarc.2025.101056_bib0019","doi-asserted-by":"crossref","first-page":"e341S","DOI":"10.1378\/chest.12-2361","article-title":"Treatment of stage IV non-small cell lung cancer: diagnosis and management of lung cancer, 3rd ed: American college of chest physicians evidence-based clinical practice guidelines","volume":"143","author":"Socinski","year":"2013","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.ctarc.2025.101056_bib0020","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s40271-018-0327-3","article-title":"Treatment decisions for advanced non-squamous non-small cell lung cancer: patient and physician perspectives on maintenance therapy","volume":"12","author":"McMullen","year":"2019","journal-title":"Patient"},{"issue":"1","key":"10.1016\/j.ctarc.2025.101056_bib0021","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-56431-w","article-title":"Decision-making factors for best supportive care alone and prognostic factors after best supportive care in non-small cell lung cancer patients","volume":"9","author":"Kitazawa","year":"2019","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.ctarc.2025.101056_bib0022","doi-asserted-by":"crossref","first-page":"205","DOI":"10.4046\/trd.2021.0179","article-title":"Prevalence and impact of comorbidities in individuals with chronic obstructive pulmonary disease: a systematic review","volume":"85","author":"Santos NC","year":"2022","journal-title":"Tuberc. Respir. Dis."},{"issue":"6","key":"10.1016\/j.ctarc.2025.101056_bib0023","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.3390\/cancers15061686","article-title":"Factors associated with the decision to decline chemotherapy in metastatic non-small cell lung cancer","volume":"15","author":"Jabbal","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.ctarc.2025.101056_bib0024","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.lungcan.2020.10.012","article-title":"Biomarker testing in non-small cell lung cancer in routine care: analysis of the first 3,717 patients in the German prospective, observational, nation-wide CRISP Registry (AIO-TRK-0315)","volume":"152","author":"Griesinger","year":"2021","journal-title":"Lung Cancer"},{"issue":"11","key":"10.1016\/j.ctarc.2025.101056_bib0025","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1002\/ijc.34868","article-title":"Patient-reported outcomes in advanced NSCLC before and during the COVID-19 pandemic: real-world data from the German prospective CRISP registry (AIO-TRK-0315)","volume":"154","author":"Sebastian","year":"2024","journal-title":"Int. J. Cancer"},{"issue":"7","key":"10.1016\/j.ctarc.2025.101056_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.jgo.2024.101819","article-title":"Real-world overview of therapeutic strategies and prognosis of older patients with advanced or metastatic non-small cell lung cancer from the ESME database","volume":"15","author":"Cabart","year":"2024","journal-title":"J. Geriatr. Oncol."},{"issue":"9","key":"10.1016\/j.ctarc.2025.101056_bib0027","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-046396","article-title":"Treatment patterns and survival outcomes for patients with non-small cell lung cancer in the UK in the preimmunology era: a REAL-oncology database analysis from the I-O Optimise initiative","volume":"11","author":"Snee","year":"2021","journal-title":"BMJ Open."},{"key":"10.1016\/j.ctarc.2025.101056_bib0028","doi-asserted-by":"crossref","first-page":"198","DOI":"10.2340\/1651-226X.2024.20309","article-title":"First-line treatment patterns and outcomes in advanced non-small cell lung cancer in Sweden: a population-based real-world study with focus on immunotherapy","volume":"63","author":"Wagenius","year":"2024","journal-title":"Acta Oncol."},{"key":"10.1016\/j.ctarc.2025.101056_bib0029","doi-asserted-by":"crossref","first-page":"415","DOI":"10.2340\/1651-226X.2025.42746","article-title":"Long-term real-world outcomes of first-line immunotherapy in non-small cell lung cancer - a population-based cohort study in Sweden","volume":"64","author":"Wagenius","year":"2025","journal-title":"Acta Oncol."},{"key":"10.1016\/j.ctarc.2025.101056_bib0030","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1442909","article-title":"Real-world treatment patterns, biomarker testing, and clinical outcomes of metastatic non-small cell lung cancer patients in the immunotherapy era","volume":"14","author":"Apter","year":"2024","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ctarc.2025.101056_bib0031","article-title":"Real-world outcomes of first-line treatment with anti-PD(L)1-based combination therapy for nonsquamous metastatic non-small cell lung cancer: a multiregional chart review in Europe, Japan, and the United States","volume":"10","author":"Liu","year":"2024","journal-title":"JCo Glob. Oncol."},{"key":"10.1016\/j.ctarc.2025.101056_bib0032","doi-asserted-by":"crossref","first-page":"123","DOI":"10.2147\/PPA.S338840","article-title":"Patient and caregiver preferences for first-line treatments of metastatic non-small cell lung cancer: a discrete choice experiment","volume":"16","author":"Yong","year":"2022","journal-title":"Patient. Prefer. Adherence"},{"issue":"3","key":"10.1016\/j.ctarc.2025.101056_bib0033","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s12094-012-0782-6","article-title":"Lung cancer chemotherapy decisions in older patients: the role of patient preference and interactions with physicians","volume":"14","author":"Giron\u00e9s","year":"2012","journal-title":"Clin. Transl. Oncol."},{"key":"10.1016\/j.ctarc.2025.101056_bib0034","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.2147\/PPA.S224529","article-title":"Patient preferences for chemotherapy in the treatment of non-small cell lung cancer: a multicenter discrete choice experiment (DCE) Study In China","volume":"13","author":"Sun","year":"2019","journal-title":"Patient. Prefer. Adheren."},{"issue":"6","key":"10.1016\/j.ctarc.2025.101056_bib0035","doi-asserted-by":"crossref","DOI":"10.1136\/esmoopen-2020-001021","article-title":"Lung cancer symptoms at diagnosis: results of a nationwide registry study","volume":"5","author":"Ruano-Ravi\u00f1a","year":"2020","journal-title":"ESMo Open."},{"issue":"692","key":"10.1016\/j.ctarc.2025.101056_bib0036","doi-asserted-by":"crossref","first-page":"e193","DOI":"10.3399\/bjgp20X708137","article-title":"Changes in the presenting symptoms of lung cancer from 2000-2017: a serial cross-sectional study of observational records in UK primary care","volume":"70","author":"Chowienczyk","year":"2020","journal-title":"Br J Gen Pr."},{"issue":"2","key":"10.1016\/j.ctarc.2025.101056_bib0037","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-032336","article-title":"Physician preferences for chemotherapy in the treatment of non-small cell lung cancer in China: evidence from multicentre discrete choice experiments","volume":"10","author":"Sun","year":"2020","journal-title":"BMJ Open."},{"issue":"4","key":"10.1016\/j.ctarc.2025.101056_bib0038","doi-asserted-by":"crossref","first-page":"249","DOI":"10.6004\/jnccn.2204.0023","article-title":"Non-small cell lung cancer, version 4.2024, NCCN clinical practice guidelines in oncology","volume":"22","author":"Riely","year":"2024","journal-title":"J. Natl. Compr. Canc. Netw."},{"issue":"3","key":"10.1016\/j.ctarc.2025.101056_bib0039","doi-asserted-by":"crossref","first-page":"254","DOI":"10.6004\/jnccn.2021.0013","article-title":"NCCN guidelines insights: non-small cell lung cancer, Version 2.2021","volume":"19","author":"Ettinger","year":"2021","journal-title":"J. Natl. Compr. Canc. Netw."},{"issue":"4","key":"10.1016\/j.ctarc.2025.101056_bib0040","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.annonc.2022.12.009","article-title":"Oncogene-addicted metastatic non-small-cell lung cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up","volume":"34","author":"Hendriks","year":"2023","journal-title":"Ann. Oncol."},{"issue":"3","key":"10.1016\/j.ctarc.2025.101056_bib0041","doi-asserted-by":"crossref","first-page":"887","DOI":"10.21037\/tlcr.2020.04.07","article-title":"Lung cancer biomarker testing: perspective from Europe","volume":"9","author":"Thunnissen","year":"2020","journal-title":"Transl. Lung Cancer Res."},{"issue":"7","key":"10.1016\/j.ctarc.2025.101056_bib0042","first-page":"867","article-title":"Lung cancer in Serbia","volume":"17","author":"Cavic","year":"2022","journal-title":"Off. Publ. Int. Assoc. Study Lung Cancer"},{"issue":"11","key":"10.1016\/j.ctarc.2025.101056_bib0043","first-page":"1492","article-title":"Lung cancer in Romania","volume":"19","author":"Olteanu","year":"2024","journal-title":"Off. Publ. Int. Assoc. Study Lung Cancer"},{"issue":"10","key":"10.1016\/j.ctarc.2025.101056_bib0044","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2025.105810","article-title":"Access to novel cancer medicines in Europe: inequities across countries and their drivers","volume":"10","author":"Hofmarcher","year":"2025","journal-title":"ESMo Open."}],"container-title":["Cancer Treatment and Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294225001923?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294225001923?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T16:54:48Z","timestamp":1770656088000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468294225001923"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":40,"alternative-id":["S2468294225001923"],"URL":"https:\/\/doi.org\/10.1016\/j.ctarc.2025.101056","relation":{},"ISSN":["2468-2942"],"issn-type":[{"value":"2468-2942","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of patient and tumor characteristics on various aspects of the non-small cell lung cancer patient journey in Romania, Bulgaria, Serbia: A multicenter, non-interventional, retrospective cohort study","name":"articletitle","label":"Article Title"},{"value":"Cancer Treatment and Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctarc.2025.101056","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101056"}}